Status:
UNKNOWN
Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT
Lead Sponsor:
Assiut University
Conditions:
Early-stage Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Role of SPECT/CT in detection of sentinel lymph node in patients with breast cancer that is in early stage with small mass with no nodal or distant metastasis using radioactive material nannocolloid t...
Detailed Description
The status of axillary lymph node involvement is the best prognostic factor in patients with early stage breast cancer. In the past; removal of all of the axillary lymph nodes (axillary lymph node dis...
Eligibility Criteria
Inclusion
- Patients 18≤ years' old, female gender.
- Patients with histopathologically proven breast cancer.
- Patients with early stage and invasive breast cancer stage T1 with mass no more than 2 cm in greatest dimension or stage T2 with mass more than 2 cm but no more than 5 cm in greatest dimension with no clinical evidence of axillary lymph node metastasis(N0) and no remote metastasis (M0).
Exclusion
- Patients with LABC, multifocal breast cancer or distant metastasis.
- Clinical, histological or radiological evidence of regional nodal metastasis.
- Prior major breast or axillary operations that could interfere with lymphatic drainage.
- Pregnancy.
- Inability to sign informed consent.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03468374
Start Date
July 1 2018
End Date
September 1 2022
Last Update
March 16 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.